Your search:
469 result(s) in 0.08 s
-
DUKAS_140420519_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured near to his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420506_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured on the balcony of his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420501_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured on the balcony of his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420533_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured on the balcony of his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420499_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured on the balcony of his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420526_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420498_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420518_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420534_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420517_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420535_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420537_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420495_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420493_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_140420538_EYE
'He taught me about love, affection and great sex': the untold story of Terrence Higgins
'He gave me a lot of space to be an awkward teenager without any confidence' Ö Rupert Whitaker.
Britain's best-known HIV charity was launched 40 years ago, but little is known about the man who inspired it. The trust's co-founders, a former partner and a close friend, reflect on his extraordinary life and legacy.
When Rupert Whitaker met Terry Higgins, he was 18 years old, callow and just starting out in life. Higgins was 37, streetwise and, although neither knew it at the time, approaching the end of his. They spent a blissful year together in which Whitaker learned so much.
Today, Higgins continues to influence his life. Whitaker, a psychiatrist and immunologist, has dedicated himself to helping people who are HIV positive in the name of Higgins.
Dr Rupert Whitaker OBE (59) pictured in his flat in New Islington , East Manchester . 40 years ago Whitaker co-founded the Terrance Higgins Trust after his partner Terry Higgins died from late-stage HIV ( AIDS ). He has been awarded an OBE for services to charity and health.
Photographed on 14/06/2022 in Manchester, UK.
© Joel Goodman / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028194_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028210_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028209_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028230_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028206_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028207_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works registering some samples in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028208_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028231_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028193_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028190_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028191_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Vaccinologist George Warimwe poses for a portrait at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028232_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028253_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother explains her son symptoms to some nurses during a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028192_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028189_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Annah Kadhengi holds her son Brighton Ushindi Baraka -who suffered malaria- while registering for a medical checkup in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028188_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holds her daughter in front of some nurses during a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028205_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Annah Kadhengi holds her son Brighton Ushindi Baraka -who suffered malaria- in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028229_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother waits with her daughter for a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028228_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother waits with her daughter for a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028183_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028187_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028185_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028226_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holding her child gets registered in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028202_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Parents wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028225_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A nurse calls a mother and her baby to be checked in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028186_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holding her child gets registered in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028203_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A boy walks from school towards his house in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028199_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A valley is seen in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028227_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Scattered houses are seen in a village in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028223_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan mothers hold their children at a waiting area while expecting to get attended for medical checkups at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028200_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother covers holds her son -who took part in the malaria vaccine trial- while two community health extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028198_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother covers hers and her young daughter’s faces -who took part in the malaria vaccine trial- while two community health extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028181_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
32-year-old Khadijah Mcharo Kapitao holds her sleeping daughter -who tested positive for malaria recently- while expecting to get attended for medical checkups in the waiting area at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028180_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holds her young daughter -who took part in the malaria vaccine trial- who is asleep while two community health gets to extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028196_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A community health worker checks on Mama Raheli’s son -who was part of the malaria vaccine trial- during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
